Accessibility Menu
Medline logo

Medline(NASDAQ) MDLN

Current Price$37.22
Market Cap$33.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-5%
5 YearN/A
1 YearN/A
1 Month+7%
Medline last closing stock price
MetricPriceDate
Last closeUSD 37.182026-07-22
Medline stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.73%USD 39.442026-07-15
1 month+7.12%USD 34.712026-06-22
3 month-19.58%USD 46.232026-04-23
Year to date-11.48%USD 42.002025-12-31
Since inception-4.66%USD 41.002025-12-17

Medline Financials at a Glance

Market Cap

$33.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$29.14B

Net Income (TTM)

$964.00M

EPS (TTM)

$1.20

P/E Ratio

32.69

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Price

$37.22

Volume

5,663,602.45

Open

$39.09

Previous Close

$37.18

Daily Range

$36.97 - $39.36

52-Week Range

$29.00 - $50.88

Estimated Earnings Date

Aug 5, 2026

MDLN News

Back room in hospital containing shelves filled with medical supplies

How to Buy Medline Stock (MDLN) in 2026

Rachel WarrenMay 20, 2026
MDLN

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio

Ryan FuhrmannFeb 5, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medline

Medline makes medical tools used by doctors and nurses every day. It helps hospitals and clinics get the supplies they need easily. These products help patients get better in many different care settings.

What Medline Sells

  • Front Line Care: Wound care, exam gloves, and skin care products for patient-facing needs in various clinical settings.
  • Surgical Solutions: Operating room supplies like surgical trays, gowns, and instruments for surgeons and hospital staff.
  • Laboratory and Diagnostics: Testing tools and monitors including vital signs equipment and point of care diagnostic devices.
  • Supply Chain Solutions: Distribution services and logistics for products from over 1,300 third-party national medical brands.

Expansion and Strategy

  • Changed its predecessor name from Mozart Holdings to Medline Holdings in December 2024.
  • Launched more than 250 new products over the last three fiscal years to expand its medical brand offerings.
  • Completed an initial public offering on December 18, 2025, listing on the Nasdaq Global Select Market.
  • Divested assets associated with its durable medical equipment supplier business unit in October 2023.

A Global Supply Network

Medline operates 70 global distribution centers and its own fleet of 2,100 MedTrans trucks to ensure next-day delivery to most U.S. customers. The company uses artificial intelligence and robotics across 26 million square feet of warehouse space to manage its 335,000 products.

The Recent Numbers

  • Revenue reached $7.8 billion in Q4 2025.
  • Net income was $180 million for the quarter ending December 31, 2025.
  • Free cash flow hit $571 million in Q4 2025.
  • Operating cash flow stood at $229 million during the fourth quarter of 2025.
  • Gross profit for the quarter ending December 31, 2025, was $1.9 billion.

Bottom Line

Medline has transformed from a family-founded business into a vertically integrated manufacturer and distributor with a massive global logistics footprint. Its primary focus remains on centralizing medical procurement through long-term partnerships with healthcare providers.

AI Generated • Apr 18, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

45,000

CEO

James M. Boyle

Website

www.medline.com

Headquarters

Northfield, IL 60093, US

MDLN Financials

Key Financial Metrics (TTM)

Gross Margin

24.04%

Operating Margin

7.04%

Net Income Margin

3.31%

Return on Equity

6.87%

Return on Capital

9.49%

Return on Assets

2.47%

Earnings Yield

3.06%

Dividend Yield

0.00%

Payout Ratio

9.96%

Stock Overview

Market Cap

$33.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

845.61M

Volume

5.66M

Avg. Volume

9.66M

Financials (TTM)

Gross Profit

$7.01B

Operating Income

$2.05B

EBITDA

$2.73B

Operating Cash Flow

$1.52B

Capital Expenditure

$5.00M

Free Cash Flow

$1.53B

Cash & ST Invst.

$2.24B

Total Debt

$12.64B

Medline Performance Analysis

Medline annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 21,448,000,000N/A
20232023-12-31USD 23,231,000,0008.3%
20242024-12-31USD 25,507,000,0009.8%
20252025-12-31USD 28,432,000,00011.5%
Medline sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.6%
Q32025-09-303.3%
Q42025-12-319.4%
Q12026-03-31-5.6%
Medline annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.03N/A
20232023-12-31USD 0.29N/A
20242024-12-31USD 1.50412.8%
20252025-12-31USD 1.43-4.9%
Medline sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-305.0%
Q32025-09-30-2.4%
Q42025-12-31-46.3%
Q12026-03-31-27.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$7.35B

+10.7%

Gross Profit

$1.67B

+1.0%

Gross Margin

22.65%

N/A

Market Cap

$33.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$734.55K

N/A

Employees

45,000

N/A

Net Income

$129.00M

-59.9%

EBITDA

$681.00M

-14.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.24B

N/A

Total Debt

$12.64B

N/A

Accounts Receivable

$3.67B

N/A

Inventory

$4.81B

N/A

Long Term Debt

$12.50B

N/A

Short Term Debt

$142.00M

N/A

Return on Assets

2.47%

N/A

Return on Invested Capital

5.62%

N/A

Free Cash Flow

$316.00M

-40.9%

Operating Cash Flow

$412.00M

-35.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RMDResMed Inc.
$192.91-1.48%
COOThe Cooper Companies, Inc.
$70.50-0.72%
AVTRAvantor, Inc.
$10.95-0.36%
BLCOBausch + Lomb Corporation
$15.95-0.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.00+0.04%
AALAmerican Airlines Group
$14.79-0.03%
PATHUiPath
$10.70-0.11%
SPCXSpace Exploration Technologies
$115.26-0.07%

Questions About MDLN

What is the current price of Medline?

Medline is trading at $37.18 per share.

What is the 52-week range for Medline?

Over the past 52 weeks, Medline has traded between $29.00 and $50.88.

How much debt does Medline have?

As of the most recent reporting period, Medline reported total debt of $12.64B.

How much cash does Medline have on hand?

Medline reported $2.24B in cash and cash equivalents in its most recent financial results.

What is Medline’s dividend yield?

Medline does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services